NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that Marino
Garcia, the company’s EVP and Chief Strategy Officer, will participate
in a fireside chat at Leerink Partners 6th Annual Global
Healthcare Conference on Wednesday, February 15, 2017 at 11:00 a.m.
Eastern Time.
A live webcast of the presentation will be accessible through the
Investor Relations section of the company’s website at www.synergypharma.com.
A replay of the webcast will be available on Synergy’s website for 60
days following the conference.
About Synergy Pharmaceuticals
Synergy is a biopharmaceutical company focused on the development and
commercialization of novel GI therapies. The company has pioneered
discovery, research and development efforts on analogs of uroguanylin, a
naturally occurring human GI peptide, for the treatment of GI diseases
and disorders. Synergy’s proprietary uroguanylin analog platform
includes one commercial product TRULANCE (plecanatide) and a second lead
product candidate – dolcanatide. For more information, please visit www.synergypharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170208005166/en/
Contacts
Synergy Pharmaceuticals:
Gem Hopkins, 212-584-7610
VP,
Investor Relations and Corporate Communications
ghopkins@synergypharma.com
Source: Synergy Pharmaceuticals Inc.
Cet article Synergy Pharmaceuticals to Present at Leerink Partners 6th
Annual Global Healthcare Conference est apparu en premier sur EEI-BIOTECHFINANCES.